Nine Masts Capital »

Ovid Therapeutics shares owned by Nine Masts Capital

Quarter-by-quarter ownership of Ovid Therapeutics (OVID) shares owned by Nine Masts Capital from 13F filings

Historical chart of Nine Masts Capital investment in Ovid Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Ovid Therapeutics held by Nine Masts Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ovid Therapeutics by Nine Masts Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $23k 14k 1.63

More positions owned by Nine Masts Capital

Alibaba Group Hldg Note 0.500% 6/0 (Principal)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Norfolk Southern (NSC)
Fox Corp Cl B Com (FOX)
Invesco Qqq Tr Unit Ser 1 (Principal) (QQQ)
Cyberark Software SHS (CYBR)
Nio Note 4.625%10/1 (Principal)
Qorvo (QRVO)
Ase Technology Hldg Sponsored Ads (ASX)
GSK Sponsored Adr (GSK)
Zillow Group Cl C Cap Stk (Z)
EXACT Sciences Corporation (EXAS)
Ryanair Holdings Sponsored Adr (RYAAY)
Jd.com Spon Ads Cl A (JD)

View all positions for Nine Masts Capital

Top funds holding Ovid Therapeutics

Takeda Pharmaceutical
Affinity Asset Advisors
ADAR1 Capital Management
Eventide Asset Management
Federated Investors
Point72 Asset Management
Vanguard Group
Saturn V Capital Management
Ally Bridge Group
Renaissance Technologies
Sio Capital Management
Driehaus Capital Management
Adage Capital Partners GP
Marshall Wace
Acadian Asset Management

View all funds holding Ovid Therapeutics